Strategic Research Objectives

• Discover the potential uniqueness of the Saudi genome and epigenome and the role of any potential genetic or epigenetic variant state in the susceptibility to diseases particular to the region.

• Use of the latest technology on the conceptualization of innovative ways for the discovery of such variations.

• Utilize the experience of our industrial partners in the fabrication of the above concepts into user-friendly and high-throughput commercial kits.

• Validation of the concept kits in clinical settings.

• Marketing of the validated kits as part of the “Personalized Medicine” approach in the health services sector in Saudi Arabia and the rest of the world. This will entails training and educating the health care about the benefits of such innovative concept to patients.

Deliverables

• Identification of the genetic and epigenetic risk factors that predispose to the common diseases in the Kingdom of Saudi Arabia.

• Elucidation of disease biomarkers and drug response modifiers.

• Validate internationally-approved biomarkers and risk factor indicators for use in the Kingdom of Saudi Arabia.

• Conceptualization of medical tests and testing kits based on the variations detected in the Saudi Genome, Epigenome and the Proteome.

• Production and marketing of clinically validated medical tests and test kits by the spin-off company established by the CIPM, Tiryaq, Inc.